FFRangio
Device Cardiology
PDI 07290017855028
General payments
$912,317
Research payments
$6,499,081
Through program year 2025, $912,317 in general payments and $6,499,081 in research payments were reported against FFRangio (Cardiology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $151,625 | 196 |
| 2025 | Research | $3,472,298 | 310 |
| 2024 | General | $112,307 | 206 |
| 2024 | Research | $2,835,336 | 277 |
| 2023 | General | $439,293 | 308 |
| 2023 | Research | $191,447 | 54 |
| 2022 | General | $148,372 | 220 |
| 2021 | General | $60,720 | 131 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 19 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 22 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,061 general · 641 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.